Report on de-novo mutation in the MSH2 gene as a rare event in hereditary nonpolyposis colorectal cancer

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 11, 2008, Pages 1101-1105

  Morak, Monika ^a,b   Laner, Andreas ^b   Scholz, Michael ^c   Maßdorf, Trisari ^a   Holinski Feder, Elke ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Center of Medical Genetics and Primary Health Care   (Armenia)

^c TRIUM ANALYSIS ONLINE GMBH   (Germany)

Author keywords

Denovo; Hereditary nonpolyposis colorectal cancer syndrome; MsH2 mutation

Indexed keywords

COMPLEMENTARY DNA; PROTEIN MSH2;

ADULT; ANAMNESIS; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC SCREENING; GERM CELL; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RNA SPLICING;

ADULT; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; DNA, NEOPLASM; FEMALE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 55349101263     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328305e185     Document Type: Article

References (24)

1. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999; 36:801-818.
2. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34:424-425.
3. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116:1453-1456.
4. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschorf J, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96:261-268.
5. Ding DC, Huang RL, Chen CH, Chao CF, Chu TY. Novel germline and somatic mutations of the MSH2 gene in hereditary non-polyposis colorectal cancer. Clin Genet 2007; 71:190-192.
6. Stulp RP, Vos YJ, Mol B, Karrenbeld A, de Raad M, van der Mijle HJ, et al. First report of a de novo germline mutation in the MLH1 gene. World J Gastroenterol 2006; 12:809-811.
7. Rasitova M, Zhang J, Okhowat R, Karrenbeld A, de Raad M, van der Mijle HJ, et al. A de novo MLH1 germ line mutation in a 31-year-old colorectal cancer patient. Genes Chromosomes Cancer 2006; 45:1106-1110.
8. Kraus C, Kastl S, Gunther K, Kiessinger S, Hohenberger W, Ballhausen WG. A proven de novo germline mutation in HNPCC. J Med Genet 1999; 36:919-921.
9. Mueller-Koch Y, Vogelsang H, Kopp R, Lohse P, Keller G, Aust D, et al. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 2005; 54: 1733-1740.
10. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997; 57:4749-4756.
11. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58:5248-5257.
12. Grabowski M, Muelter-Koch Y, Grasbon-Frodl E, Koehter D, Keller G, Vogelsang H, et al. Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families. Gener Test 2005; 9:138-146.
13. Holinski-Feder E, Muller-Koch Y, Friedl W, Moeslein G, Keller G, Raschke J, et al. DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and HMSH2. J Biochem Biophys Methods 2001; 47:21-32.
14. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 1991; 19:4008.
15. Genuardi M, Viel A, Bonora D, Capozzi E, Bellacosa A, Leonardi F, et al. Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility. Hum Genet 1998; 102:15-20.
16. Mori Y, Shiwaku H, Fukushige S, Wakatsuki S, Sato M, Nukiwa T, et al. Alternative splicing of hMSH2 in normal human tissues. Hum Genet 1997; 99:590-595.
17. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes, Int J Cancer 1999; 81:214-218.
18. Quehenberger F, Vasen HF, van Houwelingen HC. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 2005; 42:491-496.
19. Vasen HF, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007; 44:353-362.
20. Kemnyt GA. How Well Does Paternity Confidence Match Actual Paternity? Curr Anthropol 2006; 47:513-520.
21. Sasse G, Muller H, Chakraborty R, Ott J. Estimating the frequency of nonpaternity in Switzerland. Hum Hered 1994; 44:337-343.
22. Aretz S, Uhlhaas S, Caspari R, Mangold E, Pagenstecher C, Propping P, et al. Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis. Bur J Hum Genet 2004; 12:52-58.
23. Schreibman IR, Baker M, Amos C, McGarrity TJ. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 2005; 100:476-490.
24. Westerman AM, Entius MM, Boor PP, Koole R, de Baar E, Offerhaus GJ, et al. Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum Mutat 1999; 13:476-481.